Skip to main content

California's plan for cheaper insulin collides with big pharma's price cuts

By The New York Times  
   March 27, 2023

The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.

Full story

Get the latest on healthcare leadership in your inbox.